
    
      Specific Aim #1:To determine whether intraoperative use of HNC affords cardioprotective
      benefits measured by improved echocardiographic measures of myocardial function, serum
      markers of cardiomyocyte injury, and hemodynamic indices measured immediately (at end of
      surgery) and during the short-term (initial hospitalization).
    
  